Drooid Logo
Back to story perspectives

Full Breakdown

Concerns Surround Palantir's NHS England Contract and Data Privacy

3/13/2026, 9:05:04 AM

Overview of the Controversy

Palantir Technologies, a data analytics company co-founded by Peter Thiel and Alex Karp, has secured a £330 million contract with NHS England to develop the Federated Data Platform (FDP). This initiative aims to modernize the NHS by integrating disparate health datasets. However, significant concerns have emerged regarding the potential misuse of patient data and the implications for privacy and human rights.

Key Concerns Raised

A briefing by the health justice charity Medact has highlighted fears that Palantir's software could facilitate government overreach, particularly in the context of immigration enforcement. The report warns that the interoperability of Palantir's tools might enable future UK governments to access sensitive health data for purposes akin to those employed by the U.S. Immigration and Customs Enforcement (ICE). Medact's report has garnered support from various organizations, including Amnesty International, which has called for NHS England to terminate its contract with Palantir.

Political Context and Implications

The political landscape adds another layer of complexity to the situation. Reform UK, a political party led by Nigel Farage, has proposed a UK version of ICE, which would utilize data-sharing across government departments, including the Home Office and NHS. This plan raises alarms about the potential for mass deportations and the erosion of patient confidentiality. Medact's briefing urges NHS trusts and Integrated Care Boards (ICBs) to reject the FDP, citing risks to public trust and the effectiveness of local data solutions.

Official Statements & Responses

Palantir has responded to these concerns by asserting that its software is designed to enhance patient care, claiming it has contributed to the delivery of 100,000 additional operations and a 12% reduction in discharge delays. The company maintains that any misuse of data would be illegal and in breach of contract. NHS England has defended the FDP, stating that it is already improving patient care and productivity, with over 120 NHS trusts signed up to use the platform.

Criticism from Advocacy Groups

Critics, including Medact and Amnesty International, argue that Palantir's history of involvement with controversial government agencies, such as ICE, raises serious ethical questions. They contend that the potential for data-driven abuses of power is significant, especially if future legislation allows for broader data access. The report emphasizes that the current NHS data systems do not pose the same risks as the proposed FDP.

Conflicting Reports & Gaps

While Palantir insists that its software will not be used for the purposes outlined by critics, the lack of mandatory adoption of the FDP allows local health bodies to express concerns and potentially decline its implementation. The Greater Manchester ICB has already deferred adopting the FDP, citing public trust risks and the adequacy of local data capabilities.

What's Next

As the debate continues, NHS England is expected to review its contract with Palantir in February 2027. Advocacy groups plan to hold webinars and campaigns to further inform NHS organizations about the risks associated with the FDP and to encourage them to seek alternative data management solutions.

Verbatim Quotes

“Palantir software is playing an important role in improving patient care - helping to deliver 100,000 additional operations, a 12 percent reduction in discharge delays, and the removal of 675,000 patients from waiting lists.” — Palantir Spokesperson

“Bringing together disparate health datasets onto a single platform run by Palantir could enable UK government departments, such as the Home Office and police departments, to more easily access confidential patient information," the report asserted.” — Medact Report